iRadimed Corporation (IRMD) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to the Eratomed Corporation's second quarter of 2025 Financial Results Conference Call. Currently, all participants are in a listen-only mode, and at the end of the call, we will conduct a question-and-answer session. This call is being recorded today, August 1, 2025, and contains time-sensitive, accurate information only today. Earlier, Eratomed released its financial results for the second quarter of 2025. A copy of this press release announcing the company's earnings is available under the heading News on their website at eratamed.com. A copy of the press release was also furnished to the Securities and Exchange Commission on Form 8K and can be found at sec.gov. This call is being broadcast live over the Internet on the company's website at eratamed.com, and a replay will be available on the website for the next 90 days. Some of the information in today's session will constitute forward-looking statements within the meeting of the Private Securities Litigation Reform Act of 1995. Forward-looking statements focus on future performance, results, plans, and events, and may include the company's expected future results. Eratomed reminds you that future results may differ materially from these forward-looking statements due to several risk factors. For a description of the relevant risks and uncertainties that may affect the company's business, please see the Risk Factors section of the company's most recent reports filed with the Securities and Exchange Commission, which may be obtained free from the SEC's website at sec.gov. I would now like to turn the call over to Roger Soucy, President and Chief Executive Officer of Aradamid Corporation. Mr. Soucy? Thank you, Operator. Good morning, and thank you all for joining us on today's call. I am indeed very pleased...